AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2023
May 25, 2023
30583_dirs_2023-05-24_403edc6f-8e5a-4342-b478-ceb8247122c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2023-05-23
Reporting Person: Dere Willard H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-23 | Common Stock | A | 4190 | $0.00 | Acquired | 27580 | Direct |
Footnotes
F1: Restricted stock units granted on May 23, 2023. Price not applicable.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19